Methyl chloroformate → HCID 178502124, compound
Reaction equation
[OH:1][B:2]1[C@@H:7]([NH:8][C:9](=[O:22])[CH2:10][C@H:11]2[CH2:16][CH2:15][C@H:14]([NH:17][CH2:18][CH2:19][NH:20]C)[CH2:13][CH2:12]2)[CH2:6][C:5]2[CH:23]=[CH:24][CH:25]=[C:26]([C:27]([OH:29])=[O:28])[C:4]=2[O:3]1.C1COCC1.C([O-])(O)=O.[Na+].Cl[C:41]([O:43][CH3:44])=[O:42]>O.CO>[OH:1][B:2]1[C@@H:7]([NH:8][C:9](=[O:22])[CH2:10][C@H:11]2[CH2:16][CH2:15][C@H:14]([NH:17][CH2:18][CH2:19][NH:20][C:41]([O:43][CH3:44])=[O:42])[CH2:13][CH2:12]2)[CH2:6][C:5]2[CH:23]=[CH:24][CH:25]=[C:26]([C:27]([OH:29])=[O:28])[C:4]=2[O:3]1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To (R)-2-hydroxy-3-(2-(trans-4-(2-(methylamino)ethylamino)cyclohexyl)acetamido)-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid from Example 51 (39 mg) in a mixture of H2O (1 mL), THF (1 mL) and MeOH (1 mL) was added NaHCO3 (200 mg), followed by methyl chloroformate (1.2 eq). The reaction mixture was stirred at RT overnight. The solvent was then removed in vacuo and the crude product was purified by reverse phase preparative HPLC and dried using lyophilization. ESI-MS m/z 448 (MH)+.
Workup
- customThe solvent was then removed in vacuo
- customthe crude product was purified by reverse phase preparative HPLC
- customdried
Sources & evidence
- ORD record
- ord-8c80bd33786c47ea8a1e34af4b998bf4
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912169B2
Reaction notes
Loading…